For scheduling or information, 877-CENTEGRA

Supartz Treatment

How is Supartz joint fluid therapy administered?

Supartz joint fluid therapy is administered by an injection once a week into your knee for a total of five injections. Your doctor may recommend a local anesthetic prior to injection of Supartz joint fluid therapy to minimize the possible discomfort associated with an injection.

Do I need all five injections to experience the best pain relief?

Ask your doctor. The treatment that is best for you should be determined by your physician. You may experience some pain relief before you receive the full series of five injections. However, the effectiveness of a single treatment cycle of less than five injections has not been established.

What to expect…

What should you expect following your series of injections?

The goal of Supartz joint fluid therapy is relief from pain. However, studies suggest that most patients experiencing relief do so after the full series of five injections. The actual amount and duration of pain relief varies from patient to patient.

Immediately after you have the injection and for the next 48 hours, you may need to avoid activities such as jogging, tennis, heavy lifting or standing for a long time. Please note that no treatment, including Supartz joint fluid therapy, helps in every single patient.

Potential Risks

Are there any reasons why you should not utilize Supartz joint fluid therapy?

You should not use this product if you have a known hypersensitivity (allergy) to Supartz joint fluid therapy or sodium hyaluronate preparations. Inform your doctor if you are allergic to avian proteins, feathers, and egg products. Intra-articular injections are contraindicated in cases of infections or skin diseases in the area of the injection site.

The safety and effectiveness of Supartz joint fluid therapy have not been established in pregnant women, in lactating women and in children.

Supartz is a trademark of Seikagaku; Smith & Nephew; Bioventus.
 Contents Courtesy of Seikagaku; Smith & Nephew; Bioventus